Why Checkpoint Therapeutics Skyrocketed Today
One very big stock market winner on Wednesday was Checkpoint Therapeutics (NASDAQ: CKPT). Shares of the company zoomed 19% higher after glowing coverage on its stock was initiated by an analyst.
B. Riley Securities prognosticator Justin Walsh is bullish on Checkpoint. Actually, that's understating the case considerably. Walsh is so hot on Checkpoint's prospects, he's initiating his coverage with a buy rating and an $18 per-share price target -- which was nearly seven times Tuesday's closing stock price.
Image source: Getty Images.
Source Fool.com
